Birchview Capital, LP Kiniksa Pharmaceuticals, Ltd. Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Birchview Capital, LP holds 30,006 shares of KNSA stock, worth $838,667. This represents 0.6% of its overall portfolio holdings.
Number of Shares
30,006
Previous 30,000
0.02%
Holding current value
$838,667
Previous $593,000
12.31%
% of portfolio
0.6%
Previous 0.51%
Shares
4 transactions
Others Institutions Holding KNSA
# of Institutions
8Shares Held
1.92MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$42.4 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$5.66 Million2.82% of portfolio
-
Harbor Capital Advisors, Inc.70.9KShares$1.98 Million0.08% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$1.1 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$808,4250.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $963M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...